European Union Extends Review of Agilent, Varian Deal | GenomeWeb

NEW YORK (GenomeWeb News) – European Union regulators have extended their review deadline to Jan. 20 from the previous Jan. 6 on the proposed acquisition of Varian by Agilent Technologies.

According to a Reuters report today, EU regulators extended the deadline to make a decision on the deal after Agilent agreed to remedies for competition concerns. Those remedies were not specified, and Agilent officials did not return a call seeking comment before this article was published.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.